... Email. Leave this field blank. Contact IR. Thomas Dalton Head of Investor & Public Relations (913) 942-2301. IR@cingulate.com. CTx®_4C. TwitterLinkedIn ...
News Releases. Investor Menu ... Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update ... Feb 28, 2024. Compass Therapeutics Announces ...
CTX-009 Phase 2 Results in BTC Presented at ASCO GI Presentation 1.1 MB. Live Teleconference Information. Investors Dial: 1-877-704-4453. Int'l Investors Dial ...
View the largest selection of Direct Stock Purchase Plans in the Industry? Invest Now. Need help? Our virtual agent is available 24/7 ...
Missing: ctx | Show results with:ctx
Presentations. Cingulate March 2024 Investor Presentation 3.1 MB. LD Micro Main Event XVI Presentation · CTx-1301 Psych Congress Presentation 2023 846.1 KB ...
Presentations. Investor Presentation - November 2023. Crescita Therapeutics Inc. (TSX:CTX) opened Toronto Stock Exchange on April 26, 2016. crescita-768x512.
Mar 22, 2011 · (Pink Sheets: CTXV) announced today that it has engaged Wall Street Edge Investor Relations (WSE) to provide investor relations and financial ...
People also ask
What is the role of an investor relations officer?
What does investor relations do?
What is an investor relations strategy?
What are the objectives of investor relations?
Captor Therapeutics is a high-tech pharmaceutical company focused on targeting the undruggable proteome.
Crescita Therapeutics Inc. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. View CTX.CA financial statements in full.
Missing: relations | Show results with:relations
CTX is an emerging asset management firm headquartered in Texas. We make targeted investments in early-stage companies that offer the best opportunities for ...